Tag: RBM

RBM Maturity Models and Benchmarking Against Industry Peers RBM Maturity Models and Benchmarking Against Industry Peers As clinical trials evolve, the need for effective risk-based monitoring (RBM) strategies has become paramount. The goal of RBM is to focus resources on the most significant risks associated with clinical trials, ensuring that data integrity and patient safety…

Read More “RBM Maturity Models and Benchmarking Against Industry Peers” »

Comparing Pre- and Post-RBM Performance Across Trials and Portfolios Comparing Pre- and Post-RBM Performance Across Trials and Portfolios Introduction to Risk-Based Monitoring (RBM) The landscape of clinical trials is undergoing a transformation with the adoption of Risk-Based Monitoring (RBM) methodologies. Traditional monitoring methods often lead to inefficiencies, resource wastage, and increased timelines, which can impede…

Read More “Comparing Pre- and Post-RBM Performance Across Trials and Portfolios” »

<!– Metadata Dashboards for RBM Effectiveness: What to Track Monthly and Quarterly –> Dashboards for RBM Effectiveness: What to Track Monthly and Quarterly In the realm of clinical trials, particularly for covid clinical trials, the adoption of Risk-Based Monitoring (RBM) is essential in ensuring that trial operations operate efficiently while maintaining compliance with regulatory standards….

Read More “Dashboards for RBM Effectiveness: What to Track Monthly and Quarterly” »

Defining Success Criteria for Risk-Based Monitoring Implementations Defining Success Criteria for Risk-Based Monitoring Implementations Introduction to Risk-Based Monitoring in Clinical Trials Risk-Based Monitoring (RBM) has emerged as a key strategy in the management of clinical trials, particularly in ensuring quality and compliance throughout the study lifecycle. This approach allows for the identification and mitigation of…

Read More “Defining Success Criteria for Risk-Based Monitoring Implementations” »

Linking RBM Metrics to Fewer Deviations, Faster Database Lock and Lower Cost Risk-Based Monitoring (RBM) has emerged as a pivotal approach in the conduct of pharma clinical trials, offering a more efficient, quality-driven methodology that mitigates risk while ensuring regulatory compliance. This tutorial guide outlines a systematic approach for clinical operations, regulatory affairs, and medical…

Read More “Linking RBM Metrics to Fewer Deviations, Faster Database Lock and Lower Cost” »

Measuring RBM Effectiveness: KPIs That Matter to Quality and Regulators Measuring RBM Effectiveness: KPIs That Matter to Quality and Regulators In the rapidly evolving environment of clinical trials, particularly for organizations like Sarah Cannon Clinical Trials, understanding and measuring Risk-Based Monitoring (RBM) effectiveness is critical. This tutorial serves as a comprehensive guide for clinical operations,…

Read More “Measuring RBM Effectiveness: KPIs That Matter to Quality and Regulators” »